(marketscreener.com) Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results •Total revenue of $26.6 million in the fourth quarter and $81.7 million for the full year •FINTEPLA® net product sales of $23.5 million in the fourth quarter and $74.7 million for the full...https://www.marketscreener.com/quote/stock/ZOGENIX-INC-22779450/news/Zogenix-Provides-Corporate-Update-and-Reports-Fourth-Quarterand-Full-Year-2021-Financial-Results-39610555/?utm_medium=RSS&utm_content=20220228
Zogenix is a California-based biopharmaceutical company that develops and commercializes transformative therapies for the treatment of epilepsy and mitochondrial diseases.